Fostimon (purified hFsh) / IBSA Institute Biochemical SA 
Welcome,         Profile    Billing    Logout  
 5 Diseases   4 Trials   4 Trials   28 News 
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, NN1213 / Novo Nordisk, Follistim AQ Cartridge (follitropin beta) / Organon
    Trial completion date, Trial primary completion date:  Tailored Ovarian Stimulation Based on BMI, AMH, AFC (clinicaltrials.gov) -  Apr 12, 2023   
    P4,  N=300, Recruiting, 
    Trial completion date: Jun 2021 --> Dec 2023 | Trial primary completion date: Jun 2021 --> Dec 2023
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders (clinicaltrials.gov) -  Feb 17, 2022   
    P3,  N=90, Completed, 
    Trial completion date: Jun 2021 --> Dec 2023 | Trial primary completion date: Jun 2021 --> Dec 2023 Not yet recruiting --> Completed | Trial completion date: Dec 2021 --> Sep 2021 | Trial primary completion date: Sep 2021 --> Mar 2021
  • ||||||||||  Merional (menotropin) / IBSA Institute Biochemical SA, Fostimon (purified hFsh) / IBSA Institute Biochemical SA
    Journal:  YouTube as a source of information on gonadotropin self-injections. (Pubmed Central) -  Sep 23, 2021   
    Therefore, physicians should ensure that online sources are comprehensive and reliable for the use of their patients with infertility. Also, YouTube health videos should be checked for both reliability and ethical standards.
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, NN1213 / Novo Nordisk, Follistim AQ Cartridge (follitropin beta) / Organon
    Trial completion date, Trial primary completion date:  Tailored Ovarian Stimulation Based on BMI, AMH, AFC (clinicaltrials.gov) -  Oct 22, 2020   
    P4,  N=300, Recruiting, 
    Also, YouTube health videos should be checked for both reliability and ethical standards. Trial completion date: Dec 2020 --> Jun 2021 | Trial primary completion date: Dec 2020 --> Jun 2021
  • ||||||||||  menotropin / Generic mfg.
    Enrollment change:  FSH Followed by HMG vs FSH Plus HMG in IVF (clinicaltrials.gov) -  Jun 8, 2020   
    P4,  N=530, Recruiting, 
    Trial completion date: Dec 2020 --> Jun 2021 | Trial primary completion date: Dec 2020 --> Jun 2021 N=280 --> 530
  • ||||||||||  menotropin / Generic mfg.
    Enrollment open:  FSH Followed by HMG vs FSH Plus HMG in IVF (clinicaltrials.gov) -  Jun 3, 2020   
    P4,  N=280, Recruiting, 
    N=280 --> 530 Not yet recruiting --> Recruiting
  • ||||||||||  menotropin / Generic mfg.
    New P4 trial:  FSH Followed by HMG vs FSH Plus HMG in IVF (clinicaltrials.gov) -  May 11, 2020   
    P4,  N=280, Not yet recruiting, 
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, NN1213 / Novo Nordisk, Follistim AQ Cartridge (follitropin beta) / Organon
    Trial completion date, Trial primary completion date:  Tailored Ovarian Stimulation Based on BMI, AMH, AFC (clinicaltrials.gov) -  Apr 4, 2019   
    P4,  N=300, Recruiting, 
    Not yet recruiting --> Recruiting Trial completion date: Jun 2019 --> Dec 2020 | Trial primary completion date: Dec 2018 --> Dec 2020
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, NN1213 / Novo Nordisk, Follistim AQ Cartridge (follitropin beta) / Organon
    Enrollment change, Trial termination:  Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment (clinicaltrials.gov) -  Sep 14, 2018   
    P=N/A,  N=20, Terminated, 
    Trial completion date: Jun 2019 --> Dec 2020 | Trial primary completion date: Dec 2018 --> Dec 2020 N=150 --> 20 | Recruiting --> Terminated; principal investigator left for another job, project leader retired
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Follistim AQ Cartridge (follitropin beta) / Organon
    Trial completion date, Trial primary completion date:  Tailored Ovarian Stimulation Based on BMI, AMH, AFC (clinicaltrials.gov) -  Apr 18, 2018   
    P4,  N=300, Recruiting, 
    N=150 --> 20 | Recruiting --> Terminated; principal investigator left for another job, project leader retired Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Dec 2017 --> Dec 2018
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA
    Trial completion, Trial completion date:  FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (clinicaltrials.gov) -  Mar 27, 2018   
    P4,  N=712, Completed, 
    Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed | Trial completion date: Mar 2018 --> Aug 2017
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA
    Trial primary completion date:  FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (clinicaltrials.gov) -  Oct 31, 2016   
    P4,  N=712, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Mar 2018 --> Aug 2017 Trial primary completion date: Sep 2016 --> Jun 2016
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Follistim AQ Cartridge (follitropin beta) / Organon
    Enrollment open, Trial primary completion date:  Tailored Ovarian Stimulation Based on BMI, AMH, AFC (clinicaltrials.gov) -  Oct 13, 2016   
    P4,  N=300, Recruiting, 
    Trial primary completion date: Sep 2016 --> Jun 2016 Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Dec 2017
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA
    Enrollment closed, Trial primary completion date:  FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (clinicaltrials.gov) -  Jul 22, 2016   
    P4,  N=712, Active, not recruiting, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Jun 2017 --> Dec 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Sep 2016
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA
    Trial primary completion date:  FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (clinicaltrials.gov) -  Feb 24, 2016   
    P4,  N=720, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2016 --> Sep 2016 Trial primary completion date: Jan 2016 --> Jun 2016
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Follistim AQ Cartridge (follitropin beta) / Organon
    Trial initiation date:  Tailored Ovarian Stimulation Based on BMI, AMH, AFC (clinicaltrials.gov) -  Dec 22, 2015   
    P4,  N=300, Not yet recruiting, 
    Trial primary completion date: Jan 2016 --> Jun 2016 Initiation date: Jun 2015 --> Jan 2016
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Follistim AQ Cartridge (follitropin beta) / Organon
    New P4 trial:  Tailored Ovarian Stimulation Based on BMI, AMH, AFC (clinicaltrials.gov) -  Apr 30, 2015   
    P4,  N=300, Not yet recruiting, 
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA
    Trial primary completion date:  FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (clinicaltrials.gov) -  Nov 23, 2014   
    P4,  N=720, Recruiting, 
    Initiation date: Jun 2015 --> Jan 2016 Trial primary completion date: Jan 2015 --> Jan 2016
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Bravelle (urofollitropin) / Ferring
    New P3 trial:  FSH Treatment for Non-obstructive Azoospermic Patients (clinicaltrials.gov) -  Oct 27, 2014   
    P3,  N=200, Not yet recruiting, 
  • ||||||||||  Fostimon (purified hFsh) / IBSA Institute Biochemical SA
    Enrollment open:  FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (clinicaltrials.gov) -  Apr 1, 2014   
    P4,  N=720, Recruiting, 
    Trial primary completion date: Jan 2015 --> Jan 2016 Not yet recruiting --> Recruiting